Stay updated on SPX-101 Inhalation Solution in CF Clinical Trial

Sign up to get notified when there's something new on the SPX-101 Inhalation Solution in CF Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SPX-101 Inhalation Solution in CF Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-10T02:48:29.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The page revision changed from v3.4.1 to v3.4.2; this is a minor site maintenance update with no changes to study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-16T15:27:07.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.1, replacing Revision: v3.4.0.
    Difference
    0.0%
    Check dated 2026-02-09T09:48:01.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    A new 'Show glossary' option appears, and minor metadata text changes were applied (e.g., capitalization changes to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'). The revision version updated to 'v3.4.0' while the previous 'Revision: v3.3.4' text was removed.
    Difference
    0.2%
    Check dated 2026-01-26T08:27:08.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Footer revision tag updated from v3.3.3 to v3.3.4; this is a backend/version metadata change and does not modify the study details or data shown on the page.
    Difference
    0.0%
    Check dated 2026-01-19T06:17:09.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Added a top-level 'Locations' section with regional site entries (Alberta, Ontario, Auvergne-Rhône-Alpes, Brittany Region, Haute-Normandie, Languedoc-Roussillon, Pays de la Loire Region, Provence-Alpes-Côte d'Azur Region) and removed the corresponding 'Region Locations' subsections for these regions.
    Difference
    0.9%
    Check dated 2025-12-21T21:14:27.000Z thumbnail image

Stay in the know with updates to SPX-101 Inhalation Solution in CF Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SPX-101 Inhalation Solution in CF Clinical Trial page.